Testing SEP-479 in healthy adults
This trial tests a new medication called SEP-479 in healthy volunteers to see how the body handles it. Volunteers receive either a single dose or multiple doses of the drug as part of early safety research.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age between 21 and 60 years old
- Body mass index (BMI) between 18 and 32
- In general good health
- Not currently enrolled in another clinical trial
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new experimental drug (ISM4808) in healthy adults to see how safe it is and how the body handles it. It may help researchers learn if the drug is promising for future treatments.
This study tests a new medicine called TESP-0401 in healthy people to see if it is safe and how the body handles it. It is an early-stage trial, and you will stay at a clinic for part of the study.
This is an early-stage safety study testing a new experimental drug called ZE74-0282 in healthy volunteers. Researchers want to learn how safe the drug is and how well people tolerate it before testing it in patients with a disease.
This study tests a new medicine in healthy people to see if it is safe and how the body handles it. Participating could help understand side effects before testing in patients.
This study tests a single dose of a new tablet medication (called TRTL-729) in healthy adults. It helps researchers learn how the drug is absorbed and tolerated, which is a first step in developing a treatment.
This trial tests a new medicine in healthy people to see how safe it is and how the body handles it. It may help pave the way for future treatments.
Hear when a new Healthy Volunteers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.